OBJECTIVE: To study the effect of synthetic h RLX-1 peptide on human a
nd porcine myometrium in vitro in comparison to the effect of h RLX-2
peptide. STUDY DESIGN: Myometrial strips from humans and pigs in late
pregnancy were allowed to spontaneously contract in an organ bath. Mus
cle activity seas recorded isometrically in response to varying doses
of h RLX-1. RESULTS: Synthetic h RLX-1 peptide at 0.13 mu g/mL caused
sustained and complete inhibition of pregnant pig myometrial contracti
lity, comparable to that produced by the h RLX-2 peptide, showing, for
the first time, its biologic activity in this system. However, a rang
e of concentrations of h RLX-1 peptide (0.07-7.32 mu g/mL) had no effe
ct on human myometrial contractions in vitro, whereas h RLX-2 peptide
had some, albeit minimal, activity in this system. CONCLUSION: This re
sult shows that h RLX-1 peptide does not appear to be an inhibitor of
human myometrial activity and that although the pig myometrial relaxin
receptor does not appear to distinguish between the two human relaxin
s, the human relaxin receptor might. Thus, the control of spontaneous
myometrial activity during pregnancy in the human appears to be differ
ent from that in other species.